← Pulse/Companies

Drug Farm on Pulse

Biotech

The full thread of our Drug Farm coverage — a running record of every development we've tracked, with the VC take on each.

2
Stories
2
With a headline figure
Jul 13, 2026
Since

Coverage Timeline

newest first
  1. FUNDINGWhat Post-H1 Funding Data Already Shows for Q3→
  2. FUNDINGDrug Farm Raises $55M Series D for Rare Disease Drug→

All Coverage

FUNDING86% AI, top 5 = 73.1%

What Post-H1 Funding Data Already Shows for Q3

Helsing, Gauntlet and Drug Farm's rounds this week are early evidence that H1 2026's concentration pattern -- record capital, AI capturing 86%, the top five managers taking 73.1% -- is continuing into Q3, not reversing.

Jul 14, 2026
FUNDING$55M Series D

Drug Farm Raises $55M Series D for Rare Disease Drug

Biotech Drug Farm raised a $55 million Series D to advance DF-003, a Phase 3 ALPK1 inhibitor for rare autoinflammatory disorder ROSAH syndrome, alongside DF-006, a Phase 2 immunomodulator for hepatitis B and liver cancer.

Jul 13, 2026